Alexander Kantorovich, PharmD, BCPS
Alexander Kantorovich, PharmD, BCPS
Alexander Kantorovich, PharmD, BCPS, is a Clinical Associate Professor of Pharmacy Practice at Chicago State University College of Pharmacy and Clinical Pharmacy Specialist at Advocate Christ Medical Center in Oak Lawn, Illinois. Dr. Kantorovich earned his Associate of Science degree with an emphasis in chemistry from William Rainey Harper College and received his Doctor of Pharmacy degree from the University of Illinois at Chicago College of Pharmacy. He went on to complete a 2-year pharmacotherapy residency with an emphasis in cardiology and critical care at the Cleveland Clinic and is board certified in pharmacotherapy. His research interests center around cardiovascular pharmacotherapy, anticoagulation, and anticoagulation reversal.
Aug 3, 2018 @02:30 AM
Anticoagulation for Mechanical Heart Valves During Pregnancy

Aug 2, 2018 @08:31 AM
Which LVAD type is better?

Aug 1, 2018 @12:32 PM
Although it can lead to death, PCP is preventable with appropriate prophylaxis therapy given to patients at high risk of infection.

Jul 31, 2018 @04:16 AM
What Causes More Opioid Misuse: Higher Doses or Longer Durations?

Jun 18, 2018 @08:29 AM
Both negative and positive outcomes have been observed in studies.

Jun 2, 2018 @03:00 PM
Studies explore the efficacy and safety of anticoagulation for atrial fibrillation in hemodialysis.

Mar 27, 2018 @12:00 PM
DOACs For Treatment of Venous Thromboembolism in Cancer

Mar 27, 2018 @12:00 PM
Contrast-induced nephropathy manifests as a relative increase in serum creatinine of at least 25% above baseline without other precipitating causes.

Mar 26, 2018 @12:00 PM
As the role and utilization of dual antiplatelet therapy increases, the rate of gastrointestinal bleeding events are also expected to rise.

Mar 26, 2018 @02:00 AM
A recent systematic review and meta-analysis evaluated the benefits and harms of adjunctive corticosteroids in community acquired pneumonia in 6 different trials.

Dec 18, 2017 @09:25 AM
A consensus document has been published, which gives clinicians the first set of viable guidelines to follow.

Aug 25, 2017 @07:00 AM
This may be the first drug shown to reduce mortality in the HFpEF population in the United States but will hopefully not be the last.

Jun 15, 2017 @01:05 AM
Like other non-steroidal anti-inflammatory drugs (NSAIDs), ketorolac works on cyclooxygenase enzymes (COX) and inhibits prostaglandin synthesis.

May 30, 2017 @11:20 AM
Apixaban Dosing in Dialysis

Apr 4, 2017 @02:27 AM
Morphine and Ticagrelor Drug Interaction

Feb 13, 2017 @01:39 AM
The Changing Landscape of Beta Blockers in Cirrhosis

Feb 2, 2017 @06:47 AM
The Changing Landscape of Beta Blockers in Cirrhosis

Aug 26, 2016 @02:43 AM
Some transdermal patches containing aluminum or other metal in their nonadhesive backing shouldn't be worn during MRI.

Aug 24, 2016 @03:36 AM
Recent study results suggest gabapentin is safe and effective for this indication.

Jun 22, 2016 @01:57 AM
Although it was discovered in the early 1900s, unfractionated heparin remains one of the most commonly used anticoagulants in clinical practice today.

Jun 3, 2016 @01:29 AM
Since the introduction of the Cockcroft-Gault equation to calculate creatinine clearance, there has been debate about which weight to use in the equation.